169325 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Nucleoproteins
LACTYLATED NIJMEGEN BREAKAGE SYNDROME 1 PROTEIN AND USES THEREOF
#2ANTIBODY AGAINST COATOMER PROTEIN COMPLEX SUBUNIT BETA 2
#3METHOD FOR MEASURING CELL FREE CHROMATIN
#4DNA-BARCODED NUCLEOSOMES FOR CHROMATIN MAPPING ASSAYS
#5METHODS AND SYSTEMS FOR TREATING DISEASE USING AN ATR/CHK1 SIGNALING PATHWAY INHIBITOR
#6PHOTOACTIVE ANTIBODY CONJUGATE
#7USE OF ABCG1 PHOSPHORYLATION SITE AS TUMOR BIOMARKER
#8METHODS FOR IDENTIFYING REACTIVE FUNCTIONAL CYSTEINES IN NUCLEAR PROTEINS
#9METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION
#10METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION
#11PROTEIN ANTIGEN COMBINATION FOR DETECTION OF ALZHEIMER'S DISEASE AND APPLICATION THEREOF
#12HIGH THROUGHPUT ASSAYS TO STUDY NUCLEOSOME REMODELING ENZYMES
#13METHOD FOR TRANSPLANT ORGAN HEALTH ASSESSMENT
#14SYNERGISTIC CONTROL AND DYNAMIC ASSEMBLY OF VISCOELASTIC NETWORKS AND BIOMOLECULAR CONDENSATES BY AQUEOUS LIQUID-LIQUID PHASE SEPARATION AND LIQUID-SOLID PHASE SEPARATION (AQLL-LS PS2)
#15COMPANION DIAGNOSTICS AND STRATEGIES FOR TREATMENT WITH AN ARYL HYDROCARBON RECEPTOR AGONIST COMPOUND
#16ENRICHMENT AND CHARACTERIZATION OF RARE CIRCULATING CELLS, INCLUDING PROGENITOR CELLS, FROM PERIPHERAL BLOOD, AND USES THEREOF
#17TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS
#18ENGINEERED RECOMBINANT PROTEIN-BINDING DOMAINS AS DETECTION REAGENTS
#19FATTY ACID MIMETICS AS MODULATORS OF NUCLEAR RECEPTOR TLX (NR2E1)
#20METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
#21METHODS OF TREATING EOSINOPHILIC COLITIS
#22MULTIPLEXED IMMUNOSIGNAL AMPLIFICATION USING HYBRIDIZATION CHAIN REACTION-BASED METHOD
#23BIOSENSORS FOR BIOLOGICAL OR CHEMICAL ANALYSIS AND SYSTEMS AND METHODS FOR SAME
#24METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING
#25COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING KIDNEY INJURY
#26STANDARDISATION OF NUCLEOSOME ASSAYS USING BIOLOGICALLY DERIVED CALIBRANTS
#27OFF THE SHELF PROXIMITY BIOTINYLATION ENZYME
#28TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS
#29IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER
#30SINGLE DOMAIN ANTIBODY SPECIFIC FOR PHOSPHORYLATED H2AX AND ITS USES
#31ANALYSIS OF MEASUREMENTS OF A POLYMER
#32LATERAL FLOW DETECTION DEVICE FOR ACUTE AORTIC SYNDROME
#33ANTI-CLEAVED HISTONE H3 MONOCLONAL ANTIBODY THAT SPECIFICALLY RECOGNIZES NEUTROPHIL EXTRACELLULAR TRAPS
#34Biosensors for biological or chemical analysis and systems and methods for same
#35Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
#36RAN PROTEINS AS BIOMARKERS IN CAG/CTG EXPANSION DISORDERS
#37USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION
#38METHOD FOR MEASUREMENT OF CELL FREE NUCLEOPROTEIN CHROMATIN FRAGMENTS
#39MORPHOLOGICAL MARKER STAINING
#40IMPROVED ASSAYS TO DETECT NUCLEOSOME MODIFICATIONS USING ANTIBODY-TARGETED ENZYME DIGESTION
#41Humanized Anti-TDP-43 Binding Molecules and Uses Thereof
#42COMPOSITIONS AND METHODS OF DETECTION OF PRE-SYMPTOMATIC ALS
#43NANOPLASMONIC BIOSENSOR FOR DETECTING AUTOPHAGY MARKER WITH HIGH SENSITIVITY, AND METHOD OF DETECTING AUTOPHAGY MARKER AND METHOD OF SCREENING DRUG CANDIDATE USING SAME
#44IDENTIFICATION OF HEALTH STATUS IN THE ELDERLY USING IMMUNOLOGICAL BIOMARKERS
#45Multiplexed immunosignal amplification using hybridization chain reaction-based method
#46TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS
#47MICROVESICLE HISTONE H2AX AS A BIOMARKER FOR GENOTOXIC STRESS
#48UNBLENDING OF TRANSCRIPTIONAL CONDENSATES IN HUMAN REPEAT EXPANSION DISEASE
#49SYSTEM AND METHODS FOR HIGH THROUGHPUT SCREENING OF TISSUE PREPARATION CONDITIONS
#50IGF2BP2 INHIBITORS AND USES THEREOF
#51METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#52METHOD OF USING NON-RARE CELLS TO DETECT RARE CELLS
#53ISOINDOLINE DERIVATIVES WHICH BIND TO AN ATP BINDING SITE
#54TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS
#55INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES
#56SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF
#57METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN
#58USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING ERRy INHIBITOR AS ACTIVE INGREDIENT
#59COMPOSITIONS COMPRISING MODIFIED SMARCB1 AND USES THEREOF
#60METHOD FOR THE ENRICHMENT OF CIRCULATING TUMOR DNA
#61Screening and Assessment of Carcinomas
#62METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#63TDP-43 IN DEGENERATIVE DISEASE
#64METHOD FOR THE ABSOLUTE QUANTIFICATION OF MHC MOLECULES
#65METHODS FOR IDENTIFYING DIFFERENTIAL HISTONE RETENTION FOR EPIGENETIC ALTERATIONS IN GERMLINE DNA OF ANIMALS
#66Treatment and diagnosis of inflammatory disorders
#67ASSAY FOR DETERMINING THE TYPE AND/OR STATUS OF A CELL BASED ON THE EPIGENETIC PATTERN AND THE CHROMATIN STRUCTURE
#68BIOMARKERS PREDICTIVE OF CANCER CELL RESPONSE TO ML329 OR A DERIVATIVE THEREOF
#69REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE 2-HYDROXYISOBUTYRYLATION
#70METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
#71QUANTITATIVE MAPPING OF CHROMATIN ASSOCIATED PROTEINS
#72Quantitative Centrosomal Amplification Score to Predict Local Recurrence of Ductal Carcinoma In Situ
#73Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics
#74DNA-BARCODED NUCLEOSOMES FOR CHROMATIN MAPPING ASSAYS
#75Compositions and methods for diagnosing and/or treating kidney injury
#76Biosensors for biological or chemical analysis and systems and methods for same
#77METHODS, KITS, AND SYSTEMS FOR SCORING THE IMMUNE RESPONSE TO CANCER
#78ChIP-seq assays
#79FLOW CYTOMETRY FOR MONITORING HISTONE H3 METHYLATION STATUS
#80ENHANCING T-CELL FUNCTION AND TREATING A T-CELL DYSFUNCTIONAL DISORDER WITH A COMBINATION OF AN LSD INHIBITOR AND A PD-1 BINDING ANTAGONIST
#81Use of SRSF3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
#82Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#83METHODS OF USING NON-RARE CELLS TO DETECT RARE CELLS
#84Method for isolating cell nuclei having enhanced antigenicity from fixed cells or FFPE tissue section, and antigen activator and kit therefor
#85METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#86METHOD FOR THE ENRICHMENT OF CELL FREE NUCLEOSOMES
#87Compositions and methods for quantitative assessment of DNA-protein complex density
#88METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#89Methods for diagnosis and treatment of patients having solid tumors
#90CHROMATIN PROTECTIVE THERAPEUTICS AND CHROMATIN HETEROGENEITY
#91Assays for nucleosome remodeling activity
#92COMBINATION TEST FOR COLORECTAL CANCER
#93Heterochromatin gene repression inhibitors
#94Agents for reversing epigenetic silencing of genes
#95RARE PHOSPHORYLATED HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES THAT ARE INVOLVED IN NEURONAL UPTAKE AND PROPAGATION AND APPLICATIONS THEREOF
#96AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease
#97Tumor suppressor REC8 as a biomarker for gastric cancer
#98METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
#99DETECTION OF HISTONE MODIFICATION IN CELL-FREE NUCLEOSOMES
#100Reagents and methods for detecting protein lysine 3-hydroxybutyrylation
#101Benzimidazole derivatives: preparation and pharmaceutical applications
#102SOLUBLE TCR MOLECULES AND METHODS OF USE
#103Method of using non-rare cells to detect rare cells
#104METHODS AND SYSTEMS FOR SCREENING CANDIDATE COMPOUNDS FOR THEIR POTENTIAL TO CAUSE SYSTEMIC OR HEPATIC TOXICITY
#105Compositions and methods for diagnosing and/or treating kidney injury
#106Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#107METHODS FOR THE TREATMENT OF DISORDERS RELATED TO PHOSPHORYLATION OF HISTONES
#108Methods for treatment of adenoid cystic carcinoma
#109Methods for identifying macromolecule interactions
#110HISTONES AND/OR PROADM AS MARKERS INDICATING AN ADVERSE EVENT
#111Analysis of measurements of a polymer
#112Reagents and methods for detecting protein lysine 2-hydroxyisobutyrylation
#113Reagents and methods for detecting protein crotonylation
#114METHOD FOR INFERRING ACTIVITY OF A TRANSCRIPTION FACTOR OF A SIGNAL TRANSDUCTION PATHWAY IN A SUBJECT
#115METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#116METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#117TAF1 inhibitors for the therapy of cancer
#118DNA barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
#119Treatment and diagnosis of inflammatory disorders
#120Method for the enrichment of cell free nucleosomes
#121Method for detecting nucleosomes containing histone modifications and variants
#122Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#123TDP-43 in degenerative disease
#124LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#125Biosensors for biological or chemical analysis and systems and methods for same
#126Tumor suppressor REC8 as a biomarker for gastric cancer
#127Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers
#128FLOW CYTOMETRY FOR MONITORING HISTONE H3 METHYLATION STATUS
#129USE OF CELL-FREE NUCLEOSOMES AS BIOMARKERS IN SPUTUM SAMPLES
#130Nuclear stress response in motor neuron disease and other neurological diseases
#131Biological substance quantitation method, pathological diagnosis support system, and recording medium storing computer readable program
#132ANTIBODIES SPECIFIC TO PHOSPHORYLATED OCT4 AND USE THEREOF
#133Generation of cfDNA reference material
#134INHIBITION OF CANCER GROWTH AND METASTASIS
#135P53 biomarkers
#136METHODS OF TREATMENT OF CANCER
#137METHOD OF USING NON-RARE CELLS TO DETECT RARE CELLS
#138Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#139Biosensor
#140Free histone proteins as biomarkers
#141METHOD FOR THE ENRICHMENT OF CIRCULATING TUMOR DNA
#142Methods and kits for measuring and quantifying DNA double-stranded breaks using gamma-H2AX and H2AX
#143Benzimidazole derivatives: preparation and pharmaceutical applications
#144Method to predict the pattern of locomotion in horses
#145ASSAY FOR DETERMINING THE TYPE AND/OR STATUS OF A CELL BASED ON THE EPIGENETIC PATTERN AND THE CHROMATIN STRUCTURE
#146Method for detecting cells
#147Method for detecting nucleosome adducts
#148NEUROTOXICITY BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ACUTE TRAUMATIC BRAIN AND SPINAL CORD INJURY
#149CHROMATIN-ACTIVITY-BASED CHEMOPROTEOMIC (CHAC) METHODS AND SYSTEMS FOR DISEASE MARKER DISCOVERY AND DEVELOPMENT
#150Nucleosome substrate assays
#151Cell information obtaining method and cell information obtaining apparatus
#152FLUORESCENT TWO-HYBRID (F2H) ASSAY FOR DIRECT VISUALIZATION OF PROTEIN INTERACTIONS IN LIVING CELLS
#153COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#154METHOD FOR DETECTING HISTONE MODIFICATIONS IN NUCLEOSOMES
#155Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#156Methods, kits, and systems for scoring the immune response to cancer
#157LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#158Compositions and methods for quantitative assessment of DNA-protein complex density
#159Methods and kits for isolation and analysis of a chromatin region
#160MARKERS FOR ISOCITRATE DEHYDROGENASE INHIBITORS
#161Antinuclear antibody image analysis system, antinuclear antibody image analysis method, and antinuclear antibody image analysis program
#162Method for detecting nucleosomes containing histone variants
#163Biomarker for MELK activity and methods of using same
#164Benzimidazole derivatives: preparation and pharmaceutical applications
#165Brucellosis, Q-fever, and lyme disease biomarkers and uses thereof
#166Protein Demethylases Comprising a JMJC Domain
#167Nuclear stress response in motor neuron disease and other neurological diseases
#168Methods and kits for isolation and analysis of a chromatin region
#169Diagnosis and treatment of chronic obstructive pulmonary disease (COPD) based on elevated levels of extracellular H3 protein
#170Methods for suppressing adipocyte differentiation
#171Diagnostic method and system
#172CAMELID SINGLE HEAVY-CHAIN ANTIBODY DIRECTED AGAINST CHROMATIN AND USES OF SAME
#173METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
#174Compositions and methods related to recombinant antibodies to histone posttranslational modifications
#175Method for detecting nucleosome adducts
#176METHODS FOR THE TREATMENT OF DISORDERS RELATED TO PHOSPHORYLATION OF HISTONES
#177Compositions and methods for inhibiting HMGB1 activation of melanocytes
#178Method of making a skin care composition
#179METHOD FOR DETECTING CELLS
#180Agents providing controls and standards for immunoprecipitation assays
#181Homogenous thermal shift ligand binding assay
#182Microvesicle histone H2AX as a biomarker for genotoxic stress
#183METHOD AND COMPOSITIONS FOR DETECTING BINDING TO THE PREGNANE X RECEPTOR
#184Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand
#185METHODS OF DIAGNOSING AND TREATING FIBROSIS
#186Pharmacogenic therapies targeting the metal-ion transcriptional regulation machinery in bacteria
#187METHOD FOR PREDICTING THERAPY EFFICACY USING NUCLEOSOME STRUCTURE BIOMARKERS
#188Method for detecting the presence of a gynaecological growth
#189Real-time analytical methods and systems
#190Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#191Methods and kits for isolation and analysis of a chromatin region
#192Detection of histone modification in cell-free nucleosomes
#193PGC-1beta-protein-function regulator, mitochondria-function regulator, anti-obesity agent, and screening method therefor
#194Inhibition of cancer growth and metastasis
#195AGENT FOR TREATING OR PREVENTING SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
#196Methods and compositions for use in treatment of FOXP2-related cancers
#197NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION COMPOSITION AND KIT, AND NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION METHOD
#198Agents for reversing epigenetic silencing of genes
#199Method for measuring ATR inhibition mediated increases in DNA damage
#200LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS
#201NRIP AS A BIOMARKER OF ABNORMAL FUNCTION OF MOTOR NEURONS
#202RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES
#203DNA barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
#204Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
#205Benzimidazole derivatives: preparation and pharmaceutical applications
#206Small molecules modulator of epigenetic regulation and their therapeutic applications
#207Markers for the detection of human embryo developmental quality
#208Microfluidic systems and methods for chromatin immunoprecipitation (ChIP)
#209Biosensors for biological or chemical analysis and systems and methods for same
#210REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION
#211ANALYSIS OF MEASUREMENTS OF A POLYMER
#212Method for quantitating total HMGB1 protein in biological samples
#213Reagents And Methods for Detecting Protein Lysine 3-Hydroxybutyrylation
#214METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#215Systemic genotoxicity as blood marker for allergic inflammation
#216Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient
#217REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE 2-HYDROXYISOBUTYRYLATION
#218Soluble TCR molecules and methods of use
#219METHODS OF DIAGNOSING AND TREATING AMYOTROPHIC LATERAL SCLEROSIS
#220IMMUNOASSAY METHOD AND IMMUNOASSAY KIT
#221Method for detecting nucleosome adducts
#222Mutations of histone proteins associated with proliferative disorders
#223Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#224Diagnosis and treatment of chronic obstructive pulmonary disease (COPD)
#225Sub-totipotent stem cell product and apparent hereditary modifying label thereof
#226Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#227RNA splicing alterations and U1 small nuclear ribonucleoproteins in neurodegenerative diseases
#228Genotoxicity as a biomarker for inflammation
#229Method for detecting nucleosomes
#230Method for detecting nucleosomes containing histone variants
#231Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor
#232Biomarker of asbestos exposure and mesothelioma
#233Methods and kits for isolation and analysis of a chromatin region
#234KIT FOR DIAGNOSING CARDIOMYOPATHY AND METHOD FOR PREDICTING CARDIOMYOPATHY
#235Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#236Markers associated with human double minute 2 inhibitors
#237Methods for identifying modulators of murine double minute 2
#238Sequence-specific extraction and analysis of DNA-bound proteins
#239METHOD FOR ENUMERATING EUKARYOTIC CELL MICRONUCLEI WITH AN EMPHASIS ON SIMULTANEOUSLY ACQUIRING CYTOTOXICITY AND MODE OF ACTION INFORMATION
#240THREE-DIMENSIONAL STRUCTURE OF H1N1 NUCLEOPROTEIN IN COMPLEX WITH ANTIVIRAL COMPOUNDS
#241Benzimidazole derivatives: preparation and pharmaceutical applications
#242NOVEL PHARMACEUTICAL COMBINATIONS AND METHODS FOR TREATING CANCER
#243Class II human histone deacetylases, and uses related thereto
#244METHOD FOR DIAGNOSIS, MONITORING THE EFFICACY OF A THERAPY AND FOR DEVELOPMENT OF TREATMENT FOR MULTIPLE SCLEROSIS
#245Prognosis and treatment of breast cancer
#246Genotoxicity as a biomarker for inflammation
#247PREDICTING CANCER OUTCOME
#248Small molecules modulator of epigenetic regulation and their therapeutic applications
#249PROGNOSTIC, DIAGNOSTIC, AND CANCER THERAPEUTIC USES OF FANCI AND FANCI MODULATING AGENTS
#250ANCCA as a Diagnostic Biomarker and Therapeutic Target for Breast Cancers
#251USE OF MOLECULAR MARKERS FOR THE PRECLINICAL PROFILING OF INHIBITORS OF ENZYMES HAVING HISTONE DEACETYLASE ACTIVITY
#252Modulation of NR2F6 and methods and uses thereof
#253Agents providing controls and standards for immuno-precipitation assays
#254COMBINATORIAL POST-TRANSLATIONALLY-MODIFIED HISTONE PEPTIDES, ARRAYS THEREOF, AND METHODS OF USING THE SAME
#255Method for the isolation of proteins binding to any kind nucleic acid sequence of interest
#256MEANS AND METHODS FOR IDENTIFYING AN INCREASED RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS FOR DEVELOPING RENAL MANIFESTATIONS
#257Inhibitor of HMGB protein-mediated immune response activation, and screening method
#258Cells for chromatin immunoprecipitation and methods for making
#259Asf1b as a Prognosis Marker and Therapeutic Target in Human Cancer
#260USE OF HMGB1 AS A BIOLOGICAL MARKER OF BOWEL INFLAMMATORY CONDITIONS, NON-INVASIVE METHOD FOR ITS DETECTION IN FECAL SAMPLES AND KIT THEREOF
#261PREDICTIVE BIOMARKERS FOR BREAST CANCER
#262Epigenetic mechanisms related to DNA damage and aging
#263Method for assaying histone methylation enzyme activity
#264HMG1 antibody for treating inflammatory conditions
#265Promyelocytic leukemia protein as a redox sensor
#266Epigenetic marker for the identification of T lymphocytes
#267DEVELOPMENT AND EVALUATION OF NOVEL CHINESE MATERIA MEDICA PREPARATIONS
#268METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
#269Method of Using Non-Rare Cells to Detect Rare Cells
#270COMBINATION METHODS OF DIAGNOSING CANCER IN A PATIENT
#271RIP140 regulation of glucose transport
#272H3K27me3 and Cancer
#273HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
#274INHIBITION OF HISTONE ACETYLTRANSFERASES BY CTK7A AND METHODS THEREOF
#275T-Bet Compositions and Methods of Use Thereof
#276COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
#277Detection and visualization of the cell cycle in living cells
#278Injection mould having a varying volume mould cavity
#279Modified human interferon polypeptides and their uses
#280COMPOUNDS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#281SCN5A SPLICING FACTORS AND SPLICE VARIANTS FOR USE IN DIAGNOSTIC AND PROGNOSTIC METHODS
#282Class II human histone deacetylases, and uses related thereto
#283METHODS OF DIAGNOSING INSULIN RESISTANCE AND SENSITIVITY
#284Anti-aging agents and methods to identify them
#285Detection and diagnosis of inflammatory disorders
#286Method for Evaluating Immunosuppression
#287Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
#288Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof as HIF activators
#289Antibody binding specifically to TDP-43 aggregate
#290Methods of diagnosing and treating fibrosis
#291Small molecules modulator of epigenetic regulation and their therapeutic applications
#292Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders
#293Methods of identification of novel ligands for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (NR1F3) activity
#294Agonists of NR2F6 For Immunosupression
#295Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#296csPCNA Isoform Modifications And Uses Thereof
#297Prognosis and treatment of breast cancer
#298Methods for measuring the metabolism of neurally derived biomolecules in vivo
#299COPD diagnosis
#300REGENERATION AND NEOGENESIS OF RETINAL PHOTORECEPTOR CELL USING OTX2 GENE